• Using BRSF’s EEG products, Marketing Brainology was able to identify the most effective method for dispensing COVID-19 messaging
• Collected invaluable data for the current pandemic as well as how to navigate the future

Brain Scientific (OTCQB: BRSF) is focused on developing innovative and proprietary medical devices and software. As the company works to modernize brain diagnostics through cutting-edge tech, it has also collaborated with Marketing Brainology, a neuromarketing firm that uses neuroscience to understand consumer behavior.

In 2019, Marketing Brainology conducted a test to measure Super Bowl advertisements’ impact using the NeuroCap, disposable EEG headset and NeuroEEG, a 16-channel EEG amplifier and software along with in-depth interviews and eye-tracking software; the study was repeated in 2020, confirming that one size does not fit all with consumers. The company also released a video that shows the NeuroCap in action as Marketing Brainology studies consumers’ emotional reactions to these ads (https://ibn.fm/warLu).

Marketing Brainology uses neuroscience to identify decision triggers in the human brain. The same methods used to identify Super Bowl ads’ impact was used to determine the most effective messaging for dispensing COVID-19 messaging in 2020. Inspirational messages, particularly those from doctors and nurses, were better received than alarming messages. In fact, negative dramatic messaging was more likely to be tuned out than the empathetic and inspirational messages of hope.

“These methods unlock doors regarding human nature when a crisis is at hand,” said Marketing Brainology president Michelle Adams (https://ibn.fm/An0pL). “This information supplies invaluable data for the current situation we face as well as how we should navigate the future.” Brain Scientific interviewed Adams regarding Brainology’s experience using the Brain Scientific’s EEG equipment to measure consumers’ brain activity and emotional response.

Adams pointed out several features that were important in choosing this partnership. These features include medical-grade equipment; easy setup, which is crucial for subjects with long and thick hair; not clunky or pricey; and continued dedication toward improvement

“Overall, what I admire about MemoryMD’s (a subsidiary of Brain Scientific Inc.) team is that they took the time to develop the technology,” stated Adams. “I am sure they could have rushed to market a lot sooner, but they went through their own checks and balances. Because they are medically driven… I have 100% faith that [BRSF’s] technology is top of the line — and the medical community would not accept something less. For what we need it is more than enough in terms of quality and accuracy.”

For more information, visit the company’s website at www.BrainScientific.com.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.